MYCOBACTERIUM VACCAE IN THE TREATMENT OF UVEITIS

摘要

Use of antigenic or immunoregulatory material derived from Mycobacterium vaccae in the manufacture of a therapeutic agent for treatment of uveitis. The M. vaccae is suitably in the form of dead cells, preferably billed by autoclaving. The therapeutic agent preferably contains, per dose, antigenic or immunoregulatory material from 10 7 to 10 10 M. vaccae microorganisms.